|
|
A mouse model of premature atherosclerosis in systemic lupus erythematosus |
GUO Xiaoling1, ZHU Chunhong2 |
1.Department of medicine,Sichuan Provincial Corps Hospital,Chinese People’s Armed Police Force,Chengdu 610041,China; 2.Beijing Railway Center Health and Epidemic Prevention Station Huicheng Gate Clinic,Beijing 100038,China |
|
|
Abstract Objective To explore a mouse model of premature atherosclerosis in systemic lupus erythematosus (SLE). Methods Twelve-week-old ApoE-/- mice were randomly divided into the model group and control group.The mouse model was injected with pristane intraperitoneally while the control group was injected with normal saline. After 8 weeks of high fat diet (HFD), all the animals were sacrificed, and the levels of creatinine, urea nitrogen, total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol (LDL-C), and high density lipoprotein-cholesterol (HDL-C) were detected using some commercial kits. Hematoxylin (HE) staining was used to observe the morphological changes of kidney tissue. Results Compared with the control group, TC, TG, and LDL-C were increased from (6.52±3.40)mmol/L, (0.49±0.14)mmol/L and(0.30±0.30)mmol/L to (17.53±2.32) mmol/L,(1.03±0.21) mmol/L and (1.25±0.30) mmol/L respectively (P<0.01), while the level of HDL-C was down from (1.66±0.17)mmol/L to (0.79±0.17)mmol/L (P<0.01).The levels of creatinine and urea nitrogen were increased significantly. Meanwhile, the renal pathological damage was very severe in the model group. Conclusions A mouse model of premature atherosclerosis in SLE can be established through the intraperitoneal injection with pristane in ApoE-/- mice, which will contribute to the treatment and prevention of premature atherosclerosis in SLE.
|
Received: 10 October 2018
|
|
|
|
|
[1] |
Wu G C, Liu H R, Leng R X, et al. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis [J]. Autoimmun Rev,2016,15(1):22-37.
|
[2] |
Schoenfeld S R, Kasturi S, Costenbader K H. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review [J]. Semin Arthritis Rheum, 2013, 43:77-95.
|
[3] |
刘 丽. 系统性红斑狼疮早发动脉粥样硬化临床与基础研究[D].北京:中国医学科学院北京协和医学院, 2014.
|
[4] |
Ma Z, Choudhury A, Kang S A, et al. Accelerated atherosclerosis in ApoE deficient lupus mouse models [J]. Clin Immunol,2008,127(2):168-175.
|
[5] |
Feng X, Li H, Rumbin A A, et al. ApoE-/- Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia [J]. J Lipid Res,2007,48(4):794-805.
|
[6] |
Braun N, Wade N S, Wakeland E K, et al. Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice [J]. Lupus,2008,17(12):1070-1078.
|
[7] |
Zeggar S, Watanabe K S, Teshigawara S, et al. Role of lgals9 deficiency in attenuating nephritis and arthritis in BALB/c mice in a pristane-induced lupus model [J]. Arthritis Rheumatol,2018,70(7):1089-1101.
|
[8] |
缪惠宁,贾新未,张 虹,等.降压和调脂联合治疗对高血压动脉粥样硬化的影响[J].武警医学,2015,26(3):266-268.
|
[9] |
李运肖,李 覃.新型辅助性T细胞亚群与动脉粥样硬化关系的研究进展[J].武警后勤学院学报,2015,24(3):235-238.
|
|
|
|